2Ndindjock R, Gedeon J, Meudis S, et al. Potential impact of single-risk-factor versus total risk management for the prevention of cardiovascular events in Seychelles. Bull World Health Organ, 2011,89: 286-295. 被引量：1
3Wald N J, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ,2003,326 : 1419. 被引量：1
4Carey KM, Comee MR, Donovan JL, et al. A polypill for all? Critical review of the polypill literature for primary prevention of cardiovascular disease and stroke. Ann Pharmacother, 2012,46 : 688-695. 被引量：1
5Endres M, Heusehmann PU, Laufs U, et al. Primary prevention of stroke : blood pressure, lipids, and heart failure. Eur Heart J, 2011,32:545-552. 被引量：1
6Rubinstein A, Garcfa Marti S, Souto A, et al. Generalized cost- effectiveness analysis of a package of interventions to reduce cardiovascular disease in Buenos Aires, Argentina. Cost Eft Resour Alloc ,2009,7 : 10. 被引量：1
7Zamorano J, Erdine S, Pavia A, et al. Proactive multiple cardiovascular risk factor management compared with usual care in patients with hypertension and additional risk factors: the CRUCIAL trial. Curr Med Res Opin,2011,27 : 821-833. 被引量：1
8Indian Polycap Study ( TIPS), Yusuf S, Pais P, et al. Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS) : a phase Ⅱ , double-blind, randomised trial. Lancet,2009, 373 : 1341-1351. 被引量：1
9Malekzadeh F, Marshall T, Pourshams A, et al. A pilot double- blind randomised placebo-controlled trial of the effects of fixed- dose combination therapy ("polypill ") on cardiovascular risk factors. Int J Clin Pract,2010, 64 : 1220-1227. 被引量：1
10Soliman EZ, Mendis S, Dissanayake WP, et al. A Poiypill for primary prevention of cardiovascular disease : a feasibility study of the World Health Organization. TriMs,2011,12:3. 被引量：1
8Yusuf S. Two decades of progress in preventing vascular disease. Lancet, 2002, 360(9326): 2-3. 被引量：1
9Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMI, 2003, 326(7404): 1419. 被引量：1
10Yusuf S, Pais P, Afzal R, et al. Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS) :a phase II, double-blind, randomized trial. Lancet, 2009, 373(9672): 1341-1351. 被引量：1
